Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: A meta-analysis

European Heart Journal

Volumn 30, Issue 9, 2009, Pages 1080-1087

  Alam, Mahboob ^a   Dokainish, Hisham ^a   Lakkis, Nasser M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ablation; Alcohol; Cardiomyopathy; Myectomy

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE RESECTION; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; ETHANOL; FEMALE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; SCLEROTHERAPY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 65949112259     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp016     Document Type: Article

References (40)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
2. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 2006;19:319-327.
3. Cheng TO. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: how much alcohol should be injected? Catheter Cardiovasc Interv 2005;65:313-314.
4. Delgado V, Sitges M, Andrea R, Rivera S, Masotti M, Francino A, Azqueta M, Pare C, Betriu A. Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation. Rev Esp Cardiol 2006;59:1123-1130.
5. El-Jack SS, Nasif M, Blake JW, Dixon SR, Grines CL, O'Neill WW. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. J Interv Cardiol 2007;20:73-76.
6. Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol 2007;96:864-873.
7. Haghjoo M. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation. J Electrocardiol 2007;40:357 e1-e352.
8. Holmes DR Jr, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv 2000;66: 375-389.
9. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience. Clin Res Cardiol 2008;97:234-243.
10. La Canna G, Airoldi F, Capritti E, Grimaldi A, Colombo A, Alfieri O. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM. Nat Clin Pract Cardiovasc Med 2007;4:570-576.
11. Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 2007;96:856-863.
12. van Dockum WG, Kuijer JPA, Götte MJW, ten Cate FJ, ten Berg JM, Beek AM, Twisk JWR, Marcus JT, Visser CA, van Rossum AC. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. Eur Heart J 2006;27:2833-2839.
13. Veselka J. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety. Swiss Med Wkly 2007;137:657-659.
14. Veselka J, Duchonová R, Páleníckova J, Zemánek D, Tiserová M, Linhartová K, Cervinka P. Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study. Circ J 2006;70:1550-1552.
15. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
16. Cleland WP. The Surgical Management of Obstructive Cardiomyopathy. J Cardiovasc Surg (Torino) 1963;4:489-491.
17. Delahaye F, Jegaden O, De Gevigney G, Genoud JL, Perinetti M, Montagna P, Delaye J, Mikaeloff P. Postoperative and long-term prognosis of myotomymyomectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement. Eur Heart J 1993;14:1229- 1237.
18. Fighali S, Krajcer Z, Leachman RD. Septal myomectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short- and long-term follow-up. J Am Coll Cardiol 1984;3:1127-1134.
19. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. J Thorac Cardiovasc Surg 1995;110:195-206; discussion 206-208.
20. Jault F, Gandjbakhch I, Rama A, Nataf P, Dorent R, Bors V, Pavie A, Cabrol C. Long term results of the surgical treatment of obstructive hypertrophic cardiomyopathies. Arch Mal Coeur Vaiss 1996;89:679- 684.
21. Krajcer Z, Leachman RD, Cooley DA, Coronado R. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. Circulation 1989;80:I57-I64.
22. Krajcer Z, Leachman RD, Cooley DA, Ostojic M, Coronado R. Mitral valve replacement and septal myomectomy in hypertrophic cardiomyopathy. Ten-year follow-up in 80 patients. Circulation 1988;78:I35-I43.
23. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 1961;154:181-189.
24. Wigle ED, Chrysohou A, Bigelow WG. Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol 1963;11:572-586.
25. Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S, Ralph-Edwards A, Rakowski H. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005;111:2033-2041.
26. Brown ML, Schaff HV. Surgical management of hypertrophic cardiomyopathy in 2007: what is new? World J Surg 2008;32:350-354.
27. Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Schmidt HK, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography. Z Kardiol 1998;87:191-201.
28. Faber L, Seggewiss H, Welge D, Fassbender D, Schmidt HK, Gleichmann U, Horstkotte D. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr 2004;5:347-355.
29. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750- 1755.
30. Nagueh SF, Lakkis NM, He ZX, Middleton KJ, Killip D, Zoghbi WA, Quiñones, Roberts R, Verani MS, Kleiman NS, Spencer WH III. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998;32:225-229.
31. Veselka J, Procházková S, Duchon?ová R, Bolomová-Homolová I, Páleníc?ková J, Tesar? D,C? ervinka P, Hone?k T. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv 2004;63:231-235.
32. Chang SM, Nagueh SF, Spencer WH III, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003;42:296-300.
33. Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, Sachdev B, Thaman R, McKenna WJ. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 2002;23: 1617-1624.
34. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
35. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
36. Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005;129:351-358.
37. Sitges M, Shiota T, Lever HM, Qin JX, Bauer F, Drinko JK, Agler DA, Martin MG, Greenberg NL, Smedira NG, Lytle BW, Tuzcu EM, Garcia MJ, Thomas JD. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. Am J Cardiol 2003;91:817-821.
38. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2007;49:350-357.
39. van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 2005;112:482-488.
40. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750- 1755.